Amy Beth Vanduyn Sells 3,354 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR) SVP Amy Beth Vanduyn sold 3,354 shares of the business’s stock in a transaction on Monday, April 8th. The stock was sold at an average price of $22.62, for a total value of $75,867.48. Following the transaction, the senior vice president now directly owns 123,463 shares in the company, valued at approximately $2,792,733.06. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Amy Beth Vanduyn also recently made the following trade(s):

• On Tuesday, January 16th, Amy Beth Vanduyn sold 738 shares of Phreesia stock. The stock was sold at an average price of $24.55, for a total value of $18,117.90.

Phreesia Stock Performance

Shares of PHR stock opened at $23.80 on Friday. The firm has a 50 day moving average of $24.76 and a two-hundred day moving average of $21.09. The stock has a market capitalization of $1.34 billion, a PE ratio of -9.44 and a beta of 0.92. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.02. Phreesia, Inc. has a 52 week low of $12.05 and a 52 week high of $34.98.

Phreesia (NYSE:PHR) last posted its quarterly earnings results on Thursday, March 14th. The company reported ($0.56) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.58) by $0.02. Phreesia had a negative return on equity of 53.33% and a negative net margin of 38.42%. The company had revenue of $95.00 million for the quarter, compared to analyst estimates of $93.52 million. During the same quarter last year, the company earned ($0.72) EPS. Phreesia’s revenue for the quarter was up 24.0% compared to the same quarter last year. On average, research analysts predict that Phreesia, Inc. will post -1.48 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research firms recently issued reports on PHR. Barclays began coverage on shares of Phreesia in a research report on Wednesday, January 3rd. They set an “overweight” rating and a $29.00 price objective for the company. Canaccord Genuity Group lifted their price target on shares of Phreesia from $36.00 to $37.00 and gave the company a “buy” rating in a research report on Friday, March 15th. Stephens reiterated an “overweight” rating and issued a $28.00 price objective on shares of Phreesia in a report on Friday, March 22nd. Raymond James reissued an “outperform” rating and set a $30.00 target price (up previously from $25.00) on shares of Phreesia in a research note on Friday, March 15th. Finally, Truist Financial initiated coverage on Phreesia in a research note on Monday, February 26th. They issued a “buy” rating and a $35.00 price target on the stock. Two investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $31.62.

Institutional Trading of Phreesia

Several institutional investors have recently modified their holdings of the stock. Brown Advisory Inc. grew its position in shares of Phreesia by 22.2% in the 4th quarter. Brown Advisory Inc. now owns 3,950,356 shares of the company’s stock valued at $91,451,000 after buying an additional 716,374 shares during the last quarter. FMR LLC increased its position in shares of Phreesia by 8.6% during the third quarter. FMR LLC now owns 7,856,551 shares of the company’s stock worth $146,760,000 after purchasing an additional 624,456 shares in the last quarter. Rock Springs Capital Management LP lifted its holdings in shares of Phreesia by 36.1% in the 3rd quarter. Rock Springs Capital Management LP now owns 1,776,391 shares of the company’s stock valued at $33,183,000 after purchasing an additional 471,391 shares during the last quarter. Norges Bank purchased a new position in Phreesia during the 4th quarter worth approximately $8,199,000. Finally, BlackRock Inc. increased its position in Phreesia by 5.8% during the first quarter. BlackRock Inc. now owns 6,359,641 shares of the company’s stock worth $167,640,000 after buying an additional 349,301 shares during the period. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.